Chemotherapy Combines Effectively With Anti–PD-L1 Treatment and Can Augment Antitumor Responses
Journal of Immunology - United States
doi 10.4049/jimmunol.1800275
Full Text
Open PDFAbstract
Available in full text
Date
September 12, 2018
Authors
Publisher
The American Association of Immunologists